J Hay1,2,3, K Wittmeier1,2, A MacIntosh1, B Wicklow1,2, T Duhamel3,4,5,6, E Sellers1,2, H Dean1,2, E Ready3,4, L Berard7, D Kriellaars8, G X Shen7, P Gardiner3,4,5, J McGavock1,2,3,5. 1. Children's Hospital Research Institute of Manitoba, Winnipeg, Manitoba, Canada. 2. Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. 3. Faculty of Kinesiology and Recreation Management, University of Manitoba, Winnipeg, Manitoba, Canada. 4. Health, Leisure and Human Performance Research Institute, Winnipeg, Manitoba, Canada. 5. Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. 6. Institute of Cardiovascular Sciences, St. Boniface Research Centre, Winnipeg, Manitoba, Canada. 7. Diabetes Research Group, Health Sciences Centre of Winnipeg, Winnipeg, Manitoba, Canada. 8. Faculty of Medical Rehabilitation, University of Manitoba, Winnipeg, Manitoba, Canada.
Abstract
BACKGROUND: The chronic effects of high-intensity endurance training on metabolic health outcomes in overweight adolescents remains poorly understood. OBJECTIVE: To test the hypothesis that high-intensity endurance training (ET) is superior to moderate-intensityET for improving risk factors for type 2 diabetes in overweight adolescents. DESIGN AND METHODS: In this randomized trial, 106 overweight and obese adolescents (15.2 years; 76% female; 62% Caucasian) were randomly assigned to high-intensity ET (70-85% of heart rate reserve, n=38), moderate-intensity ET (40-55% heart rate reserve; n=32) or control for 6 months (n=36). The primary and secondary outcome measures were insulin sensitivity assessed using a frequently sampled intravenous glucose tolerance test and hepatic triglyceride content with magnetic resonance spectroscopy. Exploratory outcomes were cardiorespiratory fitness, physical activity and MRI and dual x-ray absorptiometry-derived measures of adiposity. RESULTS: The study had 96% retention and attendance was 61±21% and 55±24% in the high- and moderate-intensityET arms. Intention-to-treat analyses revealed that, at follow-up, insulin sensitivity was not different between high-intensity (-1.0 mU kg(-1) min(-1); 95% confidence interval (CI): -1.6, +1.4 mU kg(-1) min(-1)) and moderate-intensity (+0.26 mU kg(-1) min(-1); 95% CI: -1.3, +1.8 mU kg(-1) min(-1)) ET arms compared with controls (interaction, P=0.97). Similarly, hepatic triglyceride at follow-up was not different in high-intensity (-1.7% fat/water (F/W); 95% CI: -7.0, +3.6% F/W) and moderate-intensity (-0.40% FW; 95% CI: -6.0, +5.3% F/W) ET compared with controls. Both high intensity (+4.4 ml per kg-FFM (fat-free mass) per minute; 95% CI: 1.7, 7.1 ml kg-FFM(-1) min(-1)) and moderate intensity (+4.4 ml kg-FFM(-1) min(-1); 95% CI: 1.6, 7.3 ml kg-FFM(-1) min(-1)) increased cardiorespiratory fitness, relative to controls (interaction P<0.001). CONCLUSIONS:ET improves cardiorespiratory fitness among obese adolescents; however, owing to lack of compliance, the influence of exercise intensity on insulin sensitivity and hepatic triglycerides remains unclear.
RCT Entities:
BACKGROUND: The chronic effects of high-intensity endurance training on metabolic health outcomes in overweight adolescents remains poorly understood. OBJECTIVE: To test the hypothesis that high-intensity endurance training (ET) is superior to moderate-intensity ET for improving risk factors for type 2 diabetes in overweight adolescents. DESIGN AND METHODS: In this randomized trial, 106 overweight and obese adolescents (15.2 years; 76% female; 62% Caucasian) were randomly assigned to high-intensity ET (70-85% of heart rate reserve, n=38), moderate-intensity ET (40-55% heart rate reserve; n=32) or control for 6 months (n=36). The primary and secondary outcome measures were insulin sensitivity assessed using a frequently sampled intravenous glucose tolerance test and hepatic triglyceride content with magnetic resonance spectroscopy. Exploratory outcomes were cardiorespiratory fitness, physical activity and MRI and dual x-ray absorptiometry-derived measures of adiposity. RESULTS: The study had 96% retention and attendance was 61±21% and 55±24% in the high- and moderate-intensity ET arms. Intention-to-treat analyses revealed that, at follow-up, insulin sensitivity was not different between high-intensity (-1.0 mU kg(-1) min(-1); 95% confidence interval (CI): -1.6, +1.4 mU kg(-1) min(-1)) and moderate-intensity (+0.26 mU kg(-1) min(-1); 95% CI: -1.3, +1.8 mU kg(-1) min(-1)) ET arms compared with controls (interaction, P=0.97). Similarly, hepatic triglyceride at follow-up was not different in high-intensity (-1.7% fat/water (F/W); 95% CI: -7.0, +3.6% F/W) and moderate-intensity (-0.40% FW; 95% CI: -6.0, +5.3% F/W) ET compared with controls. Both high intensity (+4.4 ml per kg-FFM (fat-free mass) per minute; 95% CI: 1.7, 7.1 ml kg-FFM(-1) min(-1)) and moderate intensity (+4.4 ml kg-FFM(-1) min(-1); 95% CI: 1.6, 7.3 ml kg-FFM(-1) min(-1)) increased cardiorespiratory fitness, relative to controls (interaction P<0.001). CONCLUSIONS: ET improves cardiorespiratory fitness among obese adolescents; however, owing to lack of compliance, the influence of exercise intensity on insulin sensitivity and hepatic triglycerides remains unclear.
Authors: Jonathan P Little; Jenna B Gillen; Michael E Percival; Adeel Safdar; Mark A Tarnopolsky; Zubin Punthakee; Mary E Jung; Martin J Gibala Journal: J Appl Physiol (1985) Date: 2011-08-25
Authors: Carol Ewing Garber; Bryan Blissmer; Michael R Deschenes; Barry A Franklin; Michael J Lamonte; I-Min Lee; David C Nieman; David P Swain Journal: Med Sci Sports Exerc Date: 2011-07 Impact factor: 5.411
Authors: Kristy D M Wittmeier; Brandy A Wicklow; Andrea C MacIntosh; Elizabeth A C Sellers; Lawrence N Ryner; Hacene Serrai; Philip F Gardiner; Heather J Dean; Jonathan M McGavock Journal: Obesity (Silver Spring) Date: 2012-01-05 Impact factor: 5.002
Authors: T Kue Young; Patricia J Martens; Shayne P Taback; Elizabeth A C Sellers; Heather J Dean; Mary Cheang; Bertha Flett Journal: Arch Pediatr Adolesc Med Date: 2002-07
Authors: Zhi-Ping Chen; Terry J Stephens; Sid Murthy; Benedict J Canny; Mark Hargreaves; Lee A Witters; Bruce E Kemp; Glenn K McConell Journal: Diabetes Date: 2003-09 Impact factor: 9.461
Authors: Jaana Lindström; Anne Louheranta; Marjo Mannelin; Merja Rastas; Virpi Salminen; Johan Eriksson; Matti Uusitupa; Jaakko Tuomilehto Journal: Diabetes Care Date: 2003-12 Impact factor: 19.112
Authors: Ray C Boston; Darko Stefanovski; Peter J Moate; Anne E Sumner; Richard M Watanabe; Richard N Bergman Journal: Diabetes Technol Ther Date: 2003 Impact factor: 6.118
Authors: Robert Ross; Ian Janssen; Jody Dawson; Ann-Marie Kungl; Jennifer L Kuk; Suzy L Wong; Thanh-Binh Nguyen-Duy; SoJung Lee; Katherine Kilpatrick; Robert Hudson Journal: Obes Res Date: 2004-05
Authors: Pedro Delgado-Floody; Pedro Latorre-Román; Daniel Jerez-Mayorga; Felipe Caamaño-Navarrete; Felipe García-Pinillos Journal: J Exerc Sci Fit Date: 2018-11-15 Impact factor: 3.103
Authors: Katrin A Dias; Charlotte B Ingul; Arnt E Tjønna; Shelley E Keating; Sjaan R Gomersall; Turid Follestad; Mansoureh S Hosseini; Siri M Hollekim-Strand; Torstein B Ro; Margrete Haram; Else Marie Huuse; Peter S W Davies; Peter A Cain; Gary M Leong; Jeff S Coombes Journal: Sports Med Date: 2018-03 Impact factor: 11.136
Authors: Lena Al-Khudairy; Emma Loveman; Jill L Colquitt; Emma Mead; Rebecca E Johnson; Hannah Fraser; Joan Olajide; Marie Murphy; Rochelle Marian Velho; Claire O'Malley; Liane B Azevedo; Louisa J Ells; Maria-Inti Metzendorf; Karen Rees Journal: Cochrane Database Syst Rev Date: 2017-06-22
Authors: Jonathan McGavock; Bhupendrasinh F Chauhan; Rasheda Rabbani; Sofia Dias; Nika Klaprat; Sara Boissoneault; Justin Lys; Aleksandra K Wierzbowski; Mohammad Nazmus Sakib; Ryan Zarychanski; Ahmed M Abou-Setta Journal: JAMA Netw Open Date: 2020-07-01
Authors: Camila E Orsso; Eloisa Colin-Ramirez; Catherine J Field; Karen L Madsen; Carla M Prado; Andrea M Haqq Journal: Nutrients Date: 2020-09-08 Impact factor: 5.717